RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Tax loss arrives Earlier this year Q3 is coming and the latter half of the year is going to show the fruits of all the cash flow (that could have been EBITDA had it not been reinvested) because WELL has been investing heavily in WISP and Circle medical. That's probably why you wanted to trot out their essentially flat EBITDA as a result of all that investment to suggest they aren't really growing all that much. Why don't we wait until Q3 to see what their EBITDA and cash flows are like. Well has show time and again that they can grow at a pace much higher than what you deem to be "unreasonable".
you want examples? Amwell trades in the mid 20s for that multiple but in this space it's actually hard to find companies that have psotive EBITDA. An NYU report recently pegged "healthcare services" as having an industry wide multiple of 25 and digital healthcare according to the same report is over 45.
see for yourself
https://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/vebitda.html